Global Intracranial Embolization Coils Market Growth 2026-2032
The global Intracranial Embolization Coils market size is predicted to grow from US$ 934 million in 2025 to US$ 1432 million in 2032; it is expected to grow at a CAGR of 6.3% from 2026 to 2032.
Intracranial Embolization Coils are implantable neurointerventional embolization devices delivered through microcatheters into intracranial aneurysms or other indicated neurovascular lesions to reduce or occlude blood flow through mechanical space filling, flow disruption, and thrombus formation. The products are primarily manufactured from highly radiopaque and biocompatible platinum or platinum-based alloys and are predominantly designed as detachable coil systems that permit controlled deployment, repositioning, and release under fluoroscopic guidance. Commercial configurations cover three-dimensional complex and helical geometries, multiple softness grades, secondary diameters, implant lengths, and primary coil profiles, with product portfolios typically optimized for framing, filling, finishing, or multipurpose use. Technology platforms include conventional bare platinum coils as well as hydrogel-enhanced and fiber-enhanced designs intended to improve packing performance, thrombogenic response, or mechanical characteristics. Intracranial Embolization Coils are used predominantly in endovascular treatment of intracranial aneurysms and also address selected neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulas where coil embolization is clinically indicated.
Product differentiation increasingly centers on softness, shape stability, packing efficiency, detachment reliability, and microcatheter compatibility
Asia Pacific is becoming increasingly important as domestic manufacturing, procedure penetration, and international market access expand
Competition is shifting from individual coil products toward broader neurovascular treatment portfolios and integrated procedural solutions
Demand is supported by the established clinical role of endovascular treatment for intracranial aneurysms, continued expansion of neurointerventional capabilities, greater availability of advanced vascular imaging, and wider access to specialized stroke and cerebrovascular centers. Increasing treatment penetration in emerging healthcare systems is particularly important because coil procedures require an established neurointerventional infrastructure and tend to expand as physician training, catheter laboratory capacity, and reimbursement coverage improve. Product innovation is also supporting replacement and portfolio expansion as physicians seek softer coils, stable framing structures, higher packing efficiency, and more predictable delivery and detachment performance.
The market faces pricing pressure from centralized and volume-based procurement, hospital cost controls, and stronger competition among clinically comparable coil systems. These factors are particularly relevant in China and other price-sensitive healthcare markets, where increasing domestic supply can reduce average selling prices even as procedure volumes rise. Clinical substitution also constrains addressable demand in selected aneurysm anatomies, as flow diverters and intrasaccular devices provide alternative treatment strategies. In addition, precious-metal inputs, stringent quality control, sterilization, regulatory compliance, and high commercial support requirements limit the extent to which manufacturers can offset price reductions through basic manufacturing cost savings.
The most important opportunities are concentrated in broader treatment access, product specialization, and geographic expansion. Emerging neurointerventional markets offer incremental demand as hospitals establish advanced cerebrovascular programs, while manufacturers with internationally approved coil platforms can leverage an existing product base across multiple regulatory jurisdictions. Further opportunities exist in small and complex aneurysm treatment, ultra-soft finishing products, high-volume packing designs, hydrogel or fiber-enhanced coils, and coil systems engineered for low-profile microcatheters. Chinese manufacturers are also moving from domestic substitution toward international commercialization, creating additional opportunities for competitively priced products with broader regulatory coverage.
Long-term competitive success depends on consistent implant quality, precise mechanical performance, reliable detachment, and a strong clinical evidence base rather than manufacturing scale alone. Coil behavior is highly sensitive to aneurysm morphology, catheter position, physician technique, and interaction with adjunctive devices, making product performance difficult to standardize through simple dimensional specifications. Regulatory requirements for implantable Class III neurovascular devices remain demanding, and entry into major international markets requires sustained investment in clinical evidence, quality systems, post-market surveillance, and physician education. Manufacturers must also manage portfolio complexity because commercially competitive platforms increasingly require multiple shapes, softness levels, diameters, lengths, and procedural roles.
Midstream manufacturers integrate implant design, delivery systems, detachment technology, manufacturing validation, regulatory registration, and clinical support into commercially viable coil platforms. Downstream demand comes primarily from tertiary hospitals, comprehensive stroke centers, neurosurgical centers, and neurointerventional departments, with procurement structures varying from direct hospital contracting to distributors and centralized purchasing programs. Profitability is therefore influenced not only by precious-metal and production costs but also by research and development, regulatory compliance, clinical education, distribution, inventory depth across numerous specifications, and market-access expenditure. Manufacturers with broad specification coverage and integrated neurovascular portfolios can generally achieve greater account penetration and operating leverage than suppliers dependent on a limited number of coil configurations.
By Primary Procedural Role, framing, filling, finishing, and multipurpose coils form a complementary treatment sequence rather than independent clinical applications. Framing products emphasize three-dimensional stability and aneurysm-wall conformity, while filling coils balance volume efficiency and softness. Finishing products favor very low radial force and the ability to occupy small residual spaces near the end of the procedure. Multipurpose platforms seek to reduce procedural complexity by allowing a broader range of uses from initial frame formation through final packing. This segmentation is increasingly important for product portfolio design because a competitive manufacturer must address the full procedural workflow rather than a single coil specification.
Asia Pacific is becoming increasingly important to incremental demand, with China representing a distinctive combination of expanding procedure penetration, domestic product substitution, centralized procurement, and accelerating manufacturer internationalization. Volume-based procurement has increased pricing pressure for established coil categories but has also improved access for competitive domestic products and encouraged manufacturers to optimize cost structures. Chinese suppliers are increasingly obtaining registrations and commercializing coil systems outside their home market, while Southeast Asia, India, the Middle East, and Latin America offer longer-term opportunities as neurointerventional infrastructure and specialist training expand.
This Insight Report provides a comprehensive analysis of the global Intracranial Embolization Coils landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Intracranial Embolization Coils portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Intracranial Embolization Coils market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Intracranial Embolization Coils and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Intracranial Embolization Coils.
This report presents a comprehensive overview, market shares, and growth opportunities of Intracranial Embolization Coils market by product type, application, key manufacturers and key regions and countries.
Intracranial Embolization Coils are implantable neurointerventional embolization devices delivered through microcatheters into intracranial aneurysms or other indicated neurovascular lesions to reduce or occlude blood flow through mechanical space filling, flow disruption, and thrombus formation. The products are primarily manufactured from highly radiopaque and biocompatible platinum or platinum-based alloys and are predominantly designed as detachable coil systems that permit controlled deployment, repositioning, and release under fluoroscopic guidance. Commercial configurations cover three-dimensional complex and helical geometries, multiple softness grades, secondary diameters, implant lengths, and primary coil profiles, with product portfolios typically optimized for framing, filling, finishing, or multipurpose use. Technology platforms include conventional bare platinum coils as well as hydrogel-enhanced and fiber-enhanced designs intended to improve packing performance, thrombogenic response, or mechanical characteristics. Intracranial Embolization Coils are used predominantly in endovascular treatment of intracranial aneurysms and also address selected neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulas where coil embolization is clinically indicated.
Key Findings
Detachable platinum and platinum-alloy coils remain the mainstream commercial format for intracranial aneurysm embolizationProduct differentiation increasingly centers on softness, shape stability, packing efficiency, detachment reliability, and microcatheter compatibility
Asia Pacific is becoming increasingly important as domestic manufacturing, procedure penetration, and international market access expand
Competition is shifting from individual coil products toward broader neurovascular treatment portfolios and integrated procedural solutions
Market Trends
Intracranial Embolization Coils are evolving from relatively standardized metallic implants toward increasingly differentiated systems optimized for specific stages of aneurysm packing and different lesion morphologies. Manufacturers are expanding three-dimensional complex shapes, ultra-soft finishing coils, higher-volume coil structures, and broader diameter and length portfolios to improve wall conformity, frame stability, and packing efficiency while limiting radial stress on the aneurysm wall. Hydrogel-enhanced and fiber-enhanced technologies provide additional routes to increase effective filling volume or thrombogenic performance, while lower-profile delivery systems and faster, more predictable detachment mechanisms improve procedural control. At the same time, coil embolization is increasingly used within a broader lesion-specific treatment framework that also incorporates balloon assistance, coil-assist stents, flow diversion, and intrasaccular devices. This is reinforcing demand for coil portfolios that can address framing, filling, and finishing requirements rather than relying on a limited set of general-purpose products.Market Dynamics
Drivers
Demand is supported by the established clinical role of endovascular treatment for intracranial aneurysms, continued expansion of neurointerventional capabilities, greater availability of advanced vascular imaging, and wider access to specialized stroke and cerebrovascular centers. Increasing treatment penetration in emerging healthcare systems is particularly important because coil procedures require an established neurointerventional infrastructure and tend to expand as physician training, catheter laboratory capacity, and reimbursement coverage improve. Product innovation is also supporting replacement and portfolio expansion as physicians seek softer coils, stable framing structures, higher packing efficiency, and more predictable delivery and detachment performance.
Restraints
The market faces pricing pressure from centralized and volume-based procurement, hospital cost controls, and stronger competition among clinically comparable coil systems. These factors are particularly relevant in China and other price-sensitive healthcare markets, where increasing domestic supply can reduce average selling prices even as procedure volumes rise. Clinical substitution also constrains addressable demand in selected aneurysm anatomies, as flow diverters and intrasaccular devices provide alternative treatment strategies. In addition, precious-metal inputs, stringent quality control, sterilization, regulatory compliance, and high commercial support requirements limit the extent to which manufacturers can offset price reductions through basic manufacturing cost savings.
Opportunities
The most important opportunities are concentrated in broader treatment access, product specialization, and geographic expansion. Emerging neurointerventional markets offer incremental demand as hospitals establish advanced cerebrovascular programs, while manufacturers with internationally approved coil platforms can leverage an existing product base across multiple regulatory jurisdictions. Further opportunities exist in small and complex aneurysm treatment, ultra-soft finishing products, high-volume packing designs, hydrogel or fiber-enhanced coils, and coil systems engineered for low-profile microcatheters. Chinese manufacturers are also moving from domestic substitution toward international commercialization, creating additional opportunities for competitively priced products with broader regulatory coverage.
Challenges
Long-term competitive success depends on consistent implant quality, precise mechanical performance, reliable detachment, and a strong clinical evidence base rather than manufacturing scale alone. Coil behavior is highly sensitive to aneurysm morphology, catheter position, physician technique, and interaction with adjunctive devices, making product performance difficult to standardize through simple dimensional specifications. Regulatory requirements for implantable Class III neurovascular devices remain demanding, and entry into major international markets requires sustained investment in clinical evidence, quality systems, post-market surveillance, and physician education. Manufacturers must also manage portfolio complexity because commercially competitive platforms increasingly require multiple shapes, softness levels, diameters, lengths, and procedural roles.
Industry Chain Analysis
The upstream industry chain centers on high-purity platinum and platinum-based alloy wire, stainless steel and other delivery-system materials, polymer fibers, hydrogel or other functional materials, microcatheter-compatible components, packaging materials, and sterilization services. Raw material value alone does not determine product economics. Critical value creation occurs in micro-scale wire processing, primary coil winding, secondary shape setting, mechanical design, stretch-resistance structures, detachment-junction manufacturing, radiopacity control, dimensional consistency, sterile assembly, and verification of delivery performance. These processes require tight tolerances and quality systems appropriate for permanent neurovascular implants.Midstream manufacturers integrate implant design, delivery systems, detachment technology, manufacturing validation, regulatory registration, and clinical support into commercially viable coil platforms. Downstream demand comes primarily from tertiary hospitals, comprehensive stroke centers, neurosurgical centers, and neurointerventional departments, with procurement structures varying from direct hospital contracting to distributors and centralized purchasing programs. Profitability is therefore influenced not only by precious-metal and production costs but also by research and development, regulatory compliance, clinical education, distribution, inventory depth across numerous specifications, and market-access expenditure. Manufacturers with broad specification coverage and integrated neurovascular portfolios can generally achieve greater account penetration and operating leverage than suppliers dependent on a limited number of coil configurations.
Segment Insights
By Coil Technology, bare platinum and platinum-alloy coils remain the largest segment by volume because they provide an established combination of radiopacity, biocompatibility, mechanical flexibility, and broad clinical familiarity. Hydrogel-enhanced coils represent a differentiated higher-value segment focused on increasing effective packing volume, while fiber-enhanced products use additional polymer structures to modify thrombogenic or mechanical characteristics. The competitive distinction is increasingly based on clinical handling and packing performance rather than base metal composition alone, and advanced designs are expected to gain relevance in procedures where packing density and residual cavity management are particularly important.By Primary Procedural Role, framing, filling, finishing, and multipurpose coils form a complementary treatment sequence rather than independent clinical applications. Framing products emphasize three-dimensional stability and aneurysm-wall conformity, while filling coils balance volume efficiency and softness. Finishing products favor very low radial force and the ability to occupy small residual spaces near the end of the procedure. Multipurpose platforms seek to reduce procedural complexity by allowing a broader range of uses from initial frame formation through final packing. This segmentation is increasingly important for product portfolio design because a competitive manufacturer must address the full procedural workflow rather than a single coil specification.
Downstream Market Opportunities
Intracranial aneurysm treatment constitutes the principal downstream opportunity, with demand concentrated in neurointerventional and neurosurgical centers capable of performing catheter-based cerebrovascular procedures. Additional demand arises from selected arteriovenous malformations, arteriovenous fistulas, and other neurovascular lesions where coil embolization is appropriate. Future opportunities are linked less to expansion into unrelated indications than to greater diagnosis and treatment penetration, increased access to specialist centers, and broader use of endovascular therapy in emerging markets. Complex aneurysms also create demand for larger and more differentiated coil inventories because treatment frequently requires combinations of framing, filling, and finishing products together with adjunctive stents or balloons.Regional Insights
North America remains a major high-value market, supported by mature neurointerventional infrastructure, extensive adoption of premium detachable coil platforms, and broad availability of adjunctive aneurysm-treatment technologies. Europe is similarly mature but exhibits greater country-level variation in reimbursement and procurement. Japan maintains a technologically sophisticated market with established domestic and international manufacturers, while other developed Asian markets continue to adopt advanced coil systems within expanding neurovascular treatment programs.Asia Pacific is becoming increasingly important to incremental demand, with China representing a distinctive combination of expanding procedure penetration, domestic product substitution, centralized procurement, and accelerating manufacturer internationalization. Volume-based procurement has increased pricing pressure for established coil categories but has also improved access for competitive domestic products and encouraged manufacturers to optimize cost structures. Chinese suppliers are increasingly obtaining registrations and commercializing coil systems outside their home market, while Southeast Asia, India, the Middle East, and Latin America offer longer-term opportunities as neurointerventional infrastructure and specialist training expand.
Competitive Landscape Analysis
Competition in Intracranial Embolization Coils is led by multinational neurovascular platforms and specialist manufacturers with established detachable-coil technologies, extensive specification portfolios, regulatory coverage, and physician relationships. Stryker Corporation, Medtronic plc, Johnson & Johnson, Terumo Corporation, Penumbra, Inc., BALT SAS, and Kaneka Corporation compete through differentiated coil geometry, softness, packing characteristics, detachment systems, and integration with broader aneurysm-treatment portfolios, while Genesis MedTech Group provides an additional Asia-based platform. Chinese manufacturers including Wallaby Medical Holding, Inc., MicroPort NeuroScientific Corporation, Zylox-Tonbridge Medical Technology Co., Ltd., Shanghai HeartCare Medical Technology Corporation Limited, Peijia Medical Limited, Beijing Taijieweiye Technology Co., Ltd., Weigao Holding Co., Ltd., and Shunmei Medical Co., Ltd. are strengthening domestic commercialization and, in several cases, expanding international registrations and distribution. Competitive advantage is increasingly determined by full-procedure product coverage, clinical handling characteristics, reliable manufacturing, hospital access, regulatory execution, and the ability to balance procurement-driven pricing pressure with product innovation and operating efficiency.Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Intracranial Embolization Coils Industry Forecast” looks at past sales and reviews total world Intracranial Embolization Coils sales in 2025, providing a comprehensive analysis by region and market sector of projected Intracranial Embolization Coils sales for 2026 through 2032. With Intracranial Embolization Coils sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Intracranial Embolization Coils industry.This Insight Report provides a comprehensive analysis of the global Intracranial Embolization Coils landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Intracranial Embolization Coils portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Intracranial Embolization Coils market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Intracranial Embolization Coils and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Intracranial Embolization Coils.
This report presents a comprehensive overview, market shares, and growth opportunities of Intracranial Embolization Coils market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Segmentation by Type:
- Bare Platinum Coils
- Hydrogel-Enhanced Coils
- Fiber-Enhanced Coils
- Others
Segmentation by Coil Shape:
- Three-Dimensional Complex Coils
- Helical Coils
- Others
Segmentation by Detachment Method:
- Mechanical Detachment Coils
- Electrolytic Detachment Coils
- Others
Segmentation by Stretch Resistance Structure:
- Monofilament Reinforced Coils
- Multifilament Reinforced Coils
- Others
Segmentation by Application:
- Intracranial Aneurysm
- Arteriovenous Malformation (AVM)
- Cerebral Infarction
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Stryker Corporation
- Medtronic plc
- Johnson & Johnson
- Terumo Corporation
- Penumbra, Inc.
- BALT SAS
- Kaneka Corporation
- Genesis MedTech Group
- Wallaby Medical Holding, Inc.
- MicroPort NeuroScientific Corporation
- Zylox-Tonbridge Medical Technology Co., Ltd.
- Shanghai HeartCare Medical Technology Corporation Limited
- Peijia Medical Limited
- Beijing Taijieweiye Technology Co., Ltd.
- Weigao Holding Co., Ltd.
- Shunmei Medical Co., Ltd.
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Intracranial Embolization Coils market?
- What factors are driving Intracranial Embolization Coils market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Intracranial Embolization Coils market opportunities vary by end market size?
- How does Intracranial Embolization Coils break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Intracranial Embolization Coils Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Intracranial Embolization Coils by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Intracranial Embolization Coils by Country/Region, 2021, 2025 & 2032
2.2 Intracranial Embolization Coils Segment by Type
2.2.1 Bare Platinum Coils
2.2.2 Hydrogel-Enhanced Coils
2.2.3 Fiber-Enhanced Coils
2.2.4 Others
2.2.5 Intracranial Embolization Coils Sales by Type
2.2.5.1 Global Intracranial Embolization Coils Sales Market Share by Type (2021-2026)
2.2.5.2 Global Intracranial Embolization Coils Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Intracranial Embolization Coils Sale Price by Type (2021-2026)
2.3 Intracranial Embolization Coils Segment by Coil Shape
2.3.1 Three-Dimensional Complex Coils
2.3.2 Helical Coils
2.3.3 Others
2.3.4 Intracranial Embolization Coils Sales by Coil Shape
2.3.4.1 Global Intracranial Embolization Coils Sales Market Share by Coil Shape (2021-2026)
2.3.4.2 Global Intracranial Embolization Coils Revenue and Market Share by Coil Shape (2021-2026)
2.3.4.3 Global Intracranial Embolization Coils Sale Price by Coil Shape (2021-2026)
2.4 Intracranial Embolization Coils Segment by Detachment Method
2.4.1 Mechanical Detachment Coils
2.4.2 Electrolytic Detachment Coils
2.4.3 Others
2.4.4 Intracranial Embolization Coils Sales by Detachment Method
2.4.4.1 Global Intracranial Embolization Coils Sales Market Share by Detachment Method (2021-2026)
2.4.4.2 Global Intracranial Embolization Coils Revenue and Market Share by Detachment Method (2021-2026)
2.4.4.3 Global Intracranial Embolization Coils Sale Price by Detachment Method (2021-2026)
2.5 Intracranial Embolization Coils Segment by Stretch Resistance Structure
2.5.1 Monofilament Reinforced Coils
2.5.2 Multifilament Reinforced Coils
2.5.3 Others
2.5.4 Intracranial Embolization Coils Sales by Stretch Resistance Structure
2.5.4.1 Global Intracranial Embolization Coils Sales Market Share by Stretch Resistance Structure (2021-2026)
2.5.4.2 Global Intracranial Embolization Coils Revenue and Market Share by Stretch Resistance Structure (2021-2026)
2.5.4.3 Global Intracranial Embolization Coils Sale Price by Stretch Resistance Structure (2021-2026)
2.6 Intracranial Embolization Coils Segment by Application
2.6.1 Intracranial Aneurysm
2.6.2 Arteriovenous Malformation (AVM)
2.6.3 Cerebral Infarction
2.6.4 Others
2.6.5 Intracranial Embolization Coils Sales by Application
2.6.5.1 Global Intracranial Embolization Coils Sale Market Share by Application (2021-2026)
2.6.5.2 Global Intracranial Embolization Coils Revenue and Market Share by Application (2021-2026)
2.6.5.3 Global Intracranial Embolization Coils Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Intracranial Embolization Coils Breakdown Data by Company
3.1.1 Global Intracranial Embolization Coils Annual Sales by Company (2021-2026)
3.1.2 Global Intracranial Embolization Coils Sales Market Share by Company (2021-2026)
3.2 Global Intracranial Embolization Coils Annual Revenue by Company (2021-2026)
3.2.1 Global Intracranial Embolization Coils Revenue by Company (2021-2026)
3.2.2 Global Intracranial Embolization Coils Revenue Market Share by Company (2021-2026)
3.3 Global Intracranial Embolization Coils Sale Price by Company
3.4 Key Manufacturers Intracranial Embolization Coils Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Intracranial Embolization Coils Product Location Distribution
3.4.2 Players Intracranial Embolization Coils Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR INTRACRANIAL EMBOLIZATION COILS BY GEOGRAPHIC REGION
4.1 World Historic Intracranial Embolization Coils Market Size by Geographic Region (2021-2026)
4.1.1 Global Intracranial Embolization Coils Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Intracranial Embolization Coils Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Intracranial Embolization Coils Market Size by Country/Region (2021-2026)
4.2.1 Global Intracranial Embolization Coils Annual Sales by Country/Region (2021-2026)
4.2.2 Global Intracranial Embolization Coils Annual Revenue by Country/Region (2021-2026)
4.3 Americas Intracranial Embolization Coils Sales Growth
4.4 APAC Intracranial Embolization Coils Sales Growth
4.5 Europe Intracranial Embolization Coils Sales Growth
4.6 Middle East & Africa Intracranial Embolization Coils Sales Growth
5 AMERICAS
5.1 Americas Intracranial Embolization Coils Sales by Country
5.1.1 Americas Intracranial Embolization Coils Sales by Country (2021-2026)
5.1.2 Americas Intracranial Embolization Coils Revenue by Country (2021-2026)
5.2 Americas Intracranial Embolization Coils Sales by Type (2021-2026)
5.3 Americas Intracranial Embolization Coils Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Intracranial Embolization Coils Sales by Region
6.1.1 APAC Intracranial Embolization Coils Sales by Region (2021-2026)
6.1.2 APAC Intracranial Embolization Coils Revenue by Region (2021-2026)
6.2 APAC Intracranial Embolization Coils Sales by Type (2021-2026)
6.3 APAC Intracranial Embolization Coils Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Intracranial Embolization Coils by Country
7.1.1 Europe Intracranial Embolization Coils Sales by Country (2021-2026)
7.1.2 Europe Intracranial Embolization Coils Revenue by Country (2021-2026)
7.2 Europe Intracranial Embolization Coils Sales by Type (2021-2026)
7.3 Europe Intracranial Embolization Coils Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Intracranial Embolization Coils by Country
8.1.1 Middle East & Africa Intracranial Embolization Coils Sales by Country (2021-2026)
8.1.2 Middle East & Africa Intracranial Embolization Coils Revenue by Country (2021-2026)
8.2 Middle East & Africa Intracranial Embolization Coils Sales by Type (2021-2026)
8.3 Middle East & Africa Intracranial Embolization Coils Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Intracranial Embolization Coils
10.3 Manufacturing Process Analysis of Intracranial Embolization Coils
10.4 Industry Chain Structure of Intracranial Embolization Coils
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Intracranial Embolization Coils Distributors
11.3 Intracranial Embolization Coils Customer
12 WORLD FORECAST REVIEW FOR INTRACRANIAL EMBOLIZATION COILS BY GEOGRAPHIC REGION
12.1 Global Intracranial Embolization Coils Market Size Forecast by Region
12.1.1 Global Intracranial Embolization Coils Forecast by Region (2027-2032)
12.1.2 Global Intracranial Embolization Coils Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Intracranial Embolization Coils Forecast by Type (2027-2032)
12.7 Global Intracranial Embolization Coils Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Stryker Corporation
13.1.1 Stryker Corporation Company Information
13.1.2 Stryker Corporation Intracranial Embolization Coils Product Portfolios and Specifications
13.1.3 Stryker Corporation Intracranial Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Stryker Corporation Main Business Overview
13.1.5 Stryker Corporation Latest Developments
13.2 Medtronic plc
13.2.1 Medtronic plc Company Information
13.2.2 Medtronic plc Intracranial Embolization Coils Product Portfolios and Specifications
13.2.3 Medtronic plc Intracranial Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Medtronic plc Main Business Overview
13.2.5 Medtronic plc Latest Developments
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Information
13.3.2 Johnson & Johnson Intracranial Embolization Coils Product Portfolios and Specifications
13.3.3 Johnson & Johnson Intracranial Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Johnson & Johnson Main Business Overview
13.3.5 Johnson & Johnson Latest Developments
13.4 Terumo Corporation
13.4.1 Terumo Corporation Company Information
13.4.2 Terumo Corporation Intracranial Embolization Coils Product Portfolios and Specifications
13.4.3 Terumo Corporation Intracranial Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Terumo Corporation Main Business Overview
13.4.5 Terumo Corporation Latest Developments
13.5 Penumbra, Inc.
13.5.1 Penumbra, Inc. Company Information
13.5.2 Penumbra, Inc. Intracranial Embolization Coils Product Portfolios and Specifications
13.5.3 Penumbra, Inc. Intracranial Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Penumbra, Inc. Main Business Overview
13.5.5 Penumbra, Inc. Latest Developments
13.6 BALT SAS
13.6.1 BALT SAS Company Information
13.6.2 BALT SAS Intracranial Embolization Coils Product Portfolios and Specifications
13.6.3 BALT SAS Intracranial Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 BALT SAS Main Business Overview
13.6.5 BALT SAS Latest Developments
13.7 Kaneka Corporation
13.7.1 Kaneka Corporation Company Information
13.7.2 Kaneka Corporation Intracranial Embolization Coils Product Portfolios and Specifications
13.7.3 Kaneka Corporation Intracranial Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Kaneka Corporation Main Business Overview
13.7.5 Kaneka Corporation Latest Developments
13.8 Genesis MedTech Group
13.8.1 Genesis MedTech Group Company Information
13.8.2 Genesis MedTech Group Intracranial Embolization Coils Product Portfolios and Specifications
13.8.3 Genesis MedTech Group Intracranial Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Genesis MedTech Group Main Business Overview
13.8.5 Genesis MedTech Group Latest Developments
13.9 Wallaby Medical Holding, Inc.
13.9.1 Wallaby Medical Holding, Inc. Company Information
13.9.2 Wallaby Medical Holding, Inc. Intracranial Embolization Coils Product Portfolios and Specifications
13.9.3 Wallaby Medical Holding, Inc. Intracranial Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Wallaby Medical Holding, Inc. Main Business Overview
13.9.5 Wallaby Medical Holding, Inc. Latest Developments
13.10 MicroPort NeuroScientific Corporation
13.10.1 MicroPort NeuroScientific Corporation Company Information
13.10.2 MicroPort NeuroScientific Corporation Intracranial Embolization Coils Product Portfolios and Specifications
13.10.3 MicroPort NeuroScientific Corporation Intracranial Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 MicroPort NeuroScientific Corporation Main Business Overview
13.10.5 MicroPort NeuroScientific Corporation Latest Developments
13.11 Zylox-Tonbridge Medical Technology Co., Ltd.
13.11.1 Zylox-Tonbridge Medical Technology Co., Ltd. Company Information
13.11.2 Zylox-Tonbridge Medical Technology Co., Ltd. Intracranial Embolization Coils Product Portfolios and Specifications
13.11.3 Zylox-Tonbridge Medical Technology Co., Ltd. Intracranial Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Zylox-Tonbridge Medical Technology Co., Ltd. Main Business Overview
13.11.5 Zylox-Tonbridge Medical Technology Co., Ltd. Latest Developments
13.12 Shanghai HeartCare Medical Technology Corporation Limited
13.12.1 Shanghai HeartCare Medical Technology Corporation Limited Company Information
13.12.2 Shanghai HeartCare Medical Technology Corporation Limited Intracranial Embolization Coils Product Portfolios and Specifications
13.12.3 Shanghai HeartCare Medical Technology Corporation Limited Intracranial Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Shanghai HeartCare Medical Technology Corporation Limited Main Business Overview
13.12.5 Shanghai HeartCare Medical Technology Corporation Limited Latest Developments
13.13 Peijia Medical Limited
13.13.1 Peijia Medical Limited Company Information
13.13.2 Peijia Medical Limited Intracranial Embolization Coils Product Portfolios and Specifications
13.13.3 Peijia Medical Limited Intracranial Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Peijia Medical Limited Main Business Overview
13.13.5 Peijia Medical Limited Latest Developments
13.14 Beijing Taijieweiye Technology Co., Ltd.
13.14.1 Beijing Taijieweiye Technology Co., Ltd. Company Information
13.14.2 Beijing Taijieweiye Technology Co., Ltd. Intracranial Embolization Coils Product Portfolios and Specifications
13.14.3 Beijing Taijieweiye Technology Co., Ltd. Intracranial Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Beijing Taijieweiye Technology Co., Ltd. Main Business Overview
13.14.5 Beijing Taijieweiye Technology Co., Ltd. Latest Developments
13.15 Weigao Holding Co., Ltd.
13.15.1 Weigao Holding Co., Ltd. Company Information
13.15.2 Weigao Holding Co., Ltd. Intracranial Embolization Coils Product Portfolios and Specifications
13.15.3 Weigao Holding Co., Ltd. Intracranial Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Weigao Holding Co., Ltd. Main Business Overview
13.15.5 Weigao Holding Co., Ltd. Latest Developments
13.16 Shunmei Medical Co., Ltd.
13.16.1 Shunmei Medical Co., Ltd. Company Information
13.16.2 Shunmei Medical Co., Ltd. Intracranial Embolization Coils Product Portfolios and Specifications
13.16.3 Shunmei Medical Co., Ltd. Intracranial Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Shunmei Medical Co., Ltd. Main Business Overview
13.16.5 Shunmei Medical Co., Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Intracranial Embolization Coils Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Intracranial Embolization Coils by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Intracranial Embolization Coils by Country/Region, 2021, 2025 & 2032
2.2 Intracranial Embolization Coils Segment by Type
2.2.1 Bare Platinum Coils
2.2.2 Hydrogel-Enhanced Coils
2.2.3 Fiber-Enhanced Coils
2.2.4 Others
2.2.5 Intracranial Embolization Coils Sales by Type
2.2.5.1 Global Intracranial Embolization Coils Sales Market Share by Type (2021-2026)
2.2.5.2 Global Intracranial Embolization Coils Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Intracranial Embolization Coils Sale Price by Type (2021-2026)
2.3 Intracranial Embolization Coils Segment by Coil Shape
2.3.1 Three-Dimensional Complex Coils
2.3.2 Helical Coils
2.3.3 Others
2.3.4 Intracranial Embolization Coils Sales by Coil Shape
2.3.4.1 Global Intracranial Embolization Coils Sales Market Share by Coil Shape (2021-2026)
2.3.4.2 Global Intracranial Embolization Coils Revenue and Market Share by Coil Shape (2021-2026)
2.3.4.3 Global Intracranial Embolization Coils Sale Price by Coil Shape (2021-2026)
2.4 Intracranial Embolization Coils Segment by Detachment Method
2.4.1 Mechanical Detachment Coils
2.4.2 Electrolytic Detachment Coils
2.4.3 Others
2.4.4 Intracranial Embolization Coils Sales by Detachment Method
2.4.4.1 Global Intracranial Embolization Coils Sales Market Share by Detachment Method (2021-2026)
2.4.4.2 Global Intracranial Embolization Coils Revenue and Market Share by Detachment Method (2021-2026)
2.4.4.3 Global Intracranial Embolization Coils Sale Price by Detachment Method (2021-2026)
2.5 Intracranial Embolization Coils Segment by Stretch Resistance Structure
2.5.1 Monofilament Reinforced Coils
2.5.2 Multifilament Reinforced Coils
2.5.3 Others
2.5.4 Intracranial Embolization Coils Sales by Stretch Resistance Structure
2.5.4.1 Global Intracranial Embolization Coils Sales Market Share by Stretch Resistance Structure (2021-2026)
2.5.4.2 Global Intracranial Embolization Coils Revenue and Market Share by Stretch Resistance Structure (2021-2026)
2.5.4.3 Global Intracranial Embolization Coils Sale Price by Stretch Resistance Structure (2021-2026)
2.6 Intracranial Embolization Coils Segment by Application
2.6.1 Intracranial Aneurysm
2.6.2 Arteriovenous Malformation (AVM)
2.6.3 Cerebral Infarction
2.6.4 Others
2.6.5 Intracranial Embolization Coils Sales by Application
2.6.5.1 Global Intracranial Embolization Coils Sale Market Share by Application (2021-2026)
2.6.5.2 Global Intracranial Embolization Coils Revenue and Market Share by Application (2021-2026)
2.6.5.3 Global Intracranial Embolization Coils Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Intracranial Embolization Coils Breakdown Data by Company
3.1.1 Global Intracranial Embolization Coils Annual Sales by Company (2021-2026)
3.1.2 Global Intracranial Embolization Coils Sales Market Share by Company (2021-2026)
3.2 Global Intracranial Embolization Coils Annual Revenue by Company (2021-2026)
3.2.1 Global Intracranial Embolization Coils Revenue by Company (2021-2026)
3.2.2 Global Intracranial Embolization Coils Revenue Market Share by Company (2021-2026)
3.3 Global Intracranial Embolization Coils Sale Price by Company
3.4 Key Manufacturers Intracranial Embolization Coils Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Intracranial Embolization Coils Product Location Distribution
3.4.2 Players Intracranial Embolization Coils Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR INTRACRANIAL EMBOLIZATION COILS BY GEOGRAPHIC REGION
4.1 World Historic Intracranial Embolization Coils Market Size by Geographic Region (2021-2026)
4.1.1 Global Intracranial Embolization Coils Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Intracranial Embolization Coils Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Intracranial Embolization Coils Market Size by Country/Region (2021-2026)
4.2.1 Global Intracranial Embolization Coils Annual Sales by Country/Region (2021-2026)
4.2.2 Global Intracranial Embolization Coils Annual Revenue by Country/Region (2021-2026)
4.3 Americas Intracranial Embolization Coils Sales Growth
4.4 APAC Intracranial Embolization Coils Sales Growth
4.5 Europe Intracranial Embolization Coils Sales Growth
4.6 Middle East & Africa Intracranial Embolization Coils Sales Growth
5 AMERICAS
5.1 Americas Intracranial Embolization Coils Sales by Country
5.1.1 Americas Intracranial Embolization Coils Sales by Country (2021-2026)
5.1.2 Americas Intracranial Embolization Coils Revenue by Country (2021-2026)
5.2 Americas Intracranial Embolization Coils Sales by Type (2021-2026)
5.3 Americas Intracranial Embolization Coils Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Intracranial Embolization Coils Sales by Region
6.1.1 APAC Intracranial Embolization Coils Sales by Region (2021-2026)
6.1.2 APAC Intracranial Embolization Coils Revenue by Region (2021-2026)
6.2 APAC Intracranial Embolization Coils Sales by Type (2021-2026)
6.3 APAC Intracranial Embolization Coils Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Intracranial Embolization Coils by Country
7.1.1 Europe Intracranial Embolization Coils Sales by Country (2021-2026)
7.1.2 Europe Intracranial Embolization Coils Revenue by Country (2021-2026)
7.2 Europe Intracranial Embolization Coils Sales by Type (2021-2026)
7.3 Europe Intracranial Embolization Coils Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Intracranial Embolization Coils by Country
8.1.1 Middle East & Africa Intracranial Embolization Coils Sales by Country (2021-2026)
8.1.2 Middle East & Africa Intracranial Embolization Coils Revenue by Country (2021-2026)
8.2 Middle East & Africa Intracranial Embolization Coils Sales by Type (2021-2026)
8.3 Middle East & Africa Intracranial Embolization Coils Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Intracranial Embolization Coils
10.3 Manufacturing Process Analysis of Intracranial Embolization Coils
10.4 Industry Chain Structure of Intracranial Embolization Coils
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Intracranial Embolization Coils Distributors
11.3 Intracranial Embolization Coils Customer
12 WORLD FORECAST REVIEW FOR INTRACRANIAL EMBOLIZATION COILS BY GEOGRAPHIC REGION
12.1 Global Intracranial Embolization Coils Market Size Forecast by Region
12.1.1 Global Intracranial Embolization Coils Forecast by Region (2027-2032)
12.1.2 Global Intracranial Embolization Coils Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Intracranial Embolization Coils Forecast by Type (2027-2032)
12.7 Global Intracranial Embolization Coils Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Stryker Corporation
13.1.1 Stryker Corporation Company Information
13.1.2 Stryker Corporation Intracranial Embolization Coils Product Portfolios and Specifications
13.1.3 Stryker Corporation Intracranial Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Stryker Corporation Main Business Overview
13.1.5 Stryker Corporation Latest Developments
13.2 Medtronic plc
13.2.1 Medtronic plc Company Information
13.2.2 Medtronic plc Intracranial Embolization Coils Product Portfolios and Specifications
13.2.3 Medtronic plc Intracranial Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Medtronic plc Main Business Overview
13.2.5 Medtronic plc Latest Developments
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Information
13.3.2 Johnson & Johnson Intracranial Embolization Coils Product Portfolios and Specifications
13.3.3 Johnson & Johnson Intracranial Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Johnson & Johnson Main Business Overview
13.3.5 Johnson & Johnson Latest Developments
13.4 Terumo Corporation
13.4.1 Terumo Corporation Company Information
13.4.2 Terumo Corporation Intracranial Embolization Coils Product Portfolios and Specifications
13.4.3 Terumo Corporation Intracranial Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Terumo Corporation Main Business Overview
13.4.5 Terumo Corporation Latest Developments
13.5 Penumbra, Inc.
13.5.1 Penumbra, Inc. Company Information
13.5.2 Penumbra, Inc. Intracranial Embolization Coils Product Portfolios and Specifications
13.5.3 Penumbra, Inc. Intracranial Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Penumbra, Inc. Main Business Overview
13.5.5 Penumbra, Inc. Latest Developments
13.6 BALT SAS
13.6.1 BALT SAS Company Information
13.6.2 BALT SAS Intracranial Embolization Coils Product Portfolios and Specifications
13.6.3 BALT SAS Intracranial Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 BALT SAS Main Business Overview
13.6.5 BALT SAS Latest Developments
13.7 Kaneka Corporation
13.7.1 Kaneka Corporation Company Information
13.7.2 Kaneka Corporation Intracranial Embolization Coils Product Portfolios and Specifications
13.7.3 Kaneka Corporation Intracranial Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Kaneka Corporation Main Business Overview
13.7.5 Kaneka Corporation Latest Developments
13.8 Genesis MedTech Group
13.8.1 Genesis MedTech Group Company Information
13.8.2 Genesis MedTech Group Intracranial Embolization Coils Product Portfolios and Specifications
13.8.3 Genesis MedTech Group Intracranial Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Genesis MedTech Group Main Business Overview
13.8.5 Genesis MedTech Group Latest Developments
13.9 Wallaby Medical Holding, Inc.
13.9.1 Wallaby Medical Holding, Inc. Company Information
13.9.2 Wallaby Medical Holding, Inc. Intracranial Embolization Coils Product Portfolios and Specifications
13.9.3 Wallaby Medical Holding, Inc. Intracranial Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Wallaby Medical Holding, Inc. Main Business Overview
13.9.5 Wallaby Medical Holding, Inc. Latest Developments
13.10 MicroPort NeuroScientific Corporation
13.10.1 MicroPort NeuroScientific Corporation Company Information
13.10.2 MicroPort NeuroScientific Corporation Intracranial Embolization Coils Product Portfolios and Specifications
13.10.3 MicroPort NeuroScientific Corporation Intracranial Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 MicroPort NeuroScientific Corporation Main Business Overview
13.10.5 MicroPort NeuroScientific Corporation Latest Developments
13.11 Zylox-Tonbridge Medical Technology Co., Ltd.
13.11.1 Zylox-Tonbridge Medical Technology Co., Ltd. Company Information
13.11.2 Zylox-Tonbridge Medical Technology Co., Ltd. Intracranial Embolization Coils Product Portfolios and Specifications
13.11.3 Zylox-Tonbridge Medical Technology Co., Ltd. Intracranial Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Zylox-Tonbridge Medical Technology Co., Ltd. Main Business Overview
13.11.5 Zylox-Tonbridge Medical Technology Co., Ltd. Latest Developments
13.12 Shanghai HeartCare Medical Technology Corporation Limited
13.12.1 Shanghai HeartCare Medical Technology Corporation Limited Company Information
13.12.2 Shanghai HeartCare Medical Technology Corporation Limited Intracranial Embolization Coils Product Portfolios and Specifications
13.12.3 Shanghai HeartCare Medical Technology Corporation Limited Intracranial Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Shanghai HeartCare Medical Technology Corporation Limited Main Business Overview
13.12.5 Shanghai HeartCare Medical Technology Corporation Limited Latest Developments
13.13 Peijia Medical Limited
13.13.1 Peijia Medical Limited Company Information
13.13.2 Peijia Medical Limited Intracranial Embolization Coils Product Portfolios and Specifications
13.13.3 Peijia Medical Limited Intracranial Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Peijia Medical Limited Main Business Overview
13.13.5 Peijia Medical Limited Latest Developments
13.14 Beijing Taijieweiye Technology Co., Ltd.
13.14.1 Beijing Taijieweiye Technology Co., Ltd. Company Information
13.14.2 Beijing Taijieweiye Technology Co., Ltd. Intracranial Embolization Coils Product Portfolios and Specifications
13.14.3 Beijing Taijieweiye Technology Co., Ltd. Intracranial Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Beijing Taijieweiye Technology Co., Ltd. Main Business Overview
13.14.5 Beijing Taijieweiye Technology Co., Ltd. Latest Developments
13.15 Weigao Holding Co., Ltd.
13.15.1 Weigao Holding Co., Ltd. Company Information
13.15.2 Weigao Holding Co., Ltd. Intracranial Embolization Coils Product Portfolios and Specifications
13.15.3 Weigao Holding Co., Ltd. Intracranial Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Weigao Holding Co., Ltd. Main Business Overview
13.15.5 Weigao Holding Co., Ltd. Latest Developments
13.16 Shunmei Medical Co., Ltd.
13.16.1 Shunmei Medical Co., Ltd. Company Information
13.16.2 Shunmei Medical Co., Ltd. Intracranial Embolization Coils Product Portfolios and Specifications
13.16.3 Shunmei Medical Co., Ltd. Intracranial Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Shunmei Medical Co., Ltd. Main Business Overview
13.16.5 Shunmei Medical Co., Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Intracranial Embolization Coils Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Intracranial Embolization Coils Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Bare Platinum Coils
Table 4. Major Players of Hydrogel-Enhanced Coils
Table 5. Major Players of Fiber-Enhanced Coils
Table 6. Major Players of Others
Table 7. Global Intracranial Embolization Coils Sales by Type (2021-2026) & (K Units)
Table 8. Global Intracranial Embolization Coils Sales Market Share by Type (2021-2026)
Table 9. Global Intracranial Embolization Coils Revenue by Type (2021-2026) & ($ million)
Table 10. Global Intracranial Embolization Coils Revenue Market Share by Type (2021-2026)
Table 11. Global Intracranial Embolization Coils Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Major Players of Three-Dimensional Complex Coils
Table 13. Major Players of Helical Coils
Table 14. Major Players of Others
Table 15. Global Intracranial Embolization Coils Sales by Coil Shape (2021-2026) & (K Units)
Table 16. Global Intracranial Embolization Coils Sales Market Share by Coil Shape (2021-2026)
Table 17. Global Intracranial Embolization Coils Revenue by Coil Shape (2021-2026) & ($ million)
Table 18. Global Intracranial Embolization Coils Revenue Market Share by Coil Shape (2021-2026)
Table 19. Global Intracranial Embolization Coils Sale Price by Coil Shape (2021-2026) & (US$/Unit)
Table 20. Major Players of Mechanical Detachment Coils
Table 21. Major Players of Electrolytic Detachment Coils
Table 22. Major Players of Others
Table 23. Global Intracranial Embolization Coils Sales by Detachment Method (2021-2026) & (K Units)
Table 24. Global Intracranial Embolization Coils Sales Market Share by Detachment Method (2021-2026)
Table 25. Global Intracranial Embolization Coils Revenue by Detachment Method (2021-2026) & ($ million)
Table 26. Global Intracranial Embolization Coils Revenue Market Share by Detachment Method (2021-2026)
Table 27. Global Intracranial Embolization Coils Sale Price by Detachment Method (2021-2026) & (US$/Unit)
Table 28. Major Players of Monofilament Reinforced Coils
Table 29. Major Players of Multifilament Reinforced Coils
Table 30. Major Players of Others
Table 31. Global Intracranial Embolization Coils Sales by Stretch Resistance Structure (2021-2026) & (K Units)
Table 32. Global Intracranial Embolization Coils Sales Market Share by Stretch Resistance Structure (2021-2026)
Table 33. Global Intracranial Embolization Coils Revenue by Stretch Resistance Structure (2021-2026) & ($ million)
Table 34. Global Intracranial Embolization Coils Revenue Market Share by Stretch Resistance Structure (2021-2026)
Table 35. Global Intracranial Embolization Coils Sale Price by Stretch Resistance Structure (2021-2026) & (US$/Unit)
Table 36. Global Intracranial Embolization Coils Sale by Application (2021-2026) & (K Units)
Table 37. Global Intracranial Embolization Coils Sale Market Share by Application (2021-2026)
Table 38. Global Intracranial Embolization Coils Revenue by Application (2021-2026) & ($ million)
Table 39. Global Intracranial Embolization Coils Revenue Market Share by Application (2021-2026)
Table 40. Global Intracranial Embolization Coils Sale Price by Application (2021-2026) & (US$/Unit)
Table 41. Global Intracranial Embolization Coils Sales by Company (2021-2026) & (K Units)
Table 42. Global Intracranial Embolization Coils Sales Market Share by Company (2021-2026)
Table 43. Global Intracranial Embolization Coils Revenue by Company (2021-2026) & ($ millions)
Table 44. Global Intracranial Embolization Coils Revenue Market Share by Company (2021-2026)
Table 45. Global Intracranial Embolization Coils Sale Price by Company (2021-2026) & (US$/Unit)
Table 46. Key Manufacturers Intracranial Embolization Coils Producing Area Distribution and Sales Area
Table 47. Players Intracranial Embolization Coils Products Offered
Table 48. Intracranial Embolization Coils Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 49. New Products and Potential Entrants
Table 50. Market M&A Activity & Strategy
Table 51. Global Intracranial Embolization Coils Sales by Geographic Region (2021-2026) & (K Units)
Table 52. Global Intracranial Embolization Coils Sales Market Share Geographic Region (2021-2026)
Table 53. Global Intracranial Embolization Coils Revenue by Geographic Region (2021-2026) & ($ millions)
Table 54. Global Intracranial Embolization Coils Revenue Market Share by Geographic Region (2021-2026)
Table 55. Global Intracranial Embolization Coils Sales by Country/Region (2021-2026) & (K Units)
Table 56. Global Intracranial Embolization Coils Sales Market Share by Country/Region (2021-2026)
Table 57. Global Intracranial Embolization Coils Revenue by Country/Region (2021-2026) & ($ millions)
Table 58. Global Intracranial Embolization Coils Revenue Market Share by Country/Region (2021-2026)
Table 59. Americas Intracranial Embolization Coils Sales by Country (2021-2026) & (K Units)
Table 60. Americas Intracranial Embolization Coils Sales Market Share by Country (2021-2026)
Table 61. Americas Intracranial Embolization Coils Revenue by Country (2021-2026) & ($ millions)
Table 62. Americas Intracranial Embolization Coils Sales by Type (2021-2026) & (K Units)
Table 63. Americas Intracranial Embolization Coils Sales by Application (2021-2026) & (K Units)
Table 64. APAC Intracranial Embolization Coils Sales by Region (2021-2026) & (K Units)
Table 65. APAC Intracranial Embolization Coils Sales Market Share by Region (2021-2026)
Table 66. APAC Intracranial Embolization Coils Revenue by Region (2021-2026) & ($ millions)
Table 67. APAC Intracranial Embolization Coils Sales by Type (2021-2026) & (K Units)
Table 68. APAC Intracranial Embolization Coils Sales by Application (2021-2026) & (K Units)
Table 69. Europe Intracranial Embolization Coils Sales by Country (2021-2026) & (K Units)
Table 70. Europe Intracranial Embolization Coils Revenue by Country (2021-2026) & ($ millions)
Table 71. Europe Intracranial Embolization Coils Sales by Type (2021-2026) & (K Units)
Table 72. Europe Intracranial Embolization Coils Sales by Application (2021-2026) & (K Units)
Table 73. Middle East & Africa Intracranial Embolization Coils Sales by Country (2021-2026) & (K Units)
Table 74. Middle East & Africa Intracranial Embolization Coils Revenue Market Share by Country (2021-2026)
Table 75. Middle East & Africa Intracranial Embolization Coils Sales by Type (2021-2026) & (K Units)
Table 76. Middle East & Africa Intracranial Embolization Coils Sales by Application (2021-2026) & (K Units)
Table 77. Key Market Drivers & Growth Opportunities of Intracranial Embolization Coils
Table 78. Key Market Challenges & Risks of Intracranial Embolization Coils
Table 79. Key Industry Trends of Intracranial Embolization Coils
Table 80. Intracranial Embolization Coils Raw Material
Table 81. Key Suppliers of Raw Materials
Table 82. Intracranial Embolization Coils Distributors List
Table 83. Intracranial Embolization Coils Customer List
Table 84. Global Intracranial Embolization Coils Sales Forecast by Region (2027-2032) & (K Units)
Table 85. Global Intracranial Embolization Coils Revenue Forecast by Region (2027-2032) & ($ millions)
Table 86. Americas Intracranial Embolization Coils Sales Forecast by Country (2027-2032) & (K Units)
Table 87. Americas Intracranial Embolization Coils Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 88. APAC Intracranial Embolization Coils Sales Forecast by Region (2027-2032) & (K Units)
Table 89. APAC Intracranial Embolization Coils Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 90. Europe Intracranial Embolization Coils Sales Forecast by Country (2027-2032) & (K Units)
Table 91. Europe Intracranial Embolization Coils Revenue Forecast by Country (2027-2032) & ($ millions)
Table 92. Middle East & Africa Intracranial Embolization Coils Sales Forecast by Country (2027-2032) & (K Units)
Table 93. Middle East & Africa Intracranial Embolization Coils Revenue Forecast by Country (2027-2032) & ($ millions)
Table 94. Global Intracranial Embolization Coils Sales Forecast by Type (2027-2032) & (K Units)
Table 95. Global Intracranial Embolization Coils Revenue Forecast by Type (2027-2032) & ($ millions)
Table 96. Global Intracranial Embolization Coils Sales Forecast by Application (2027-2032) & (K Units)
Table 97. Global Intracranial Embolization Coils Revenue Forecast by Application (2027-2032) & ($ millions)
Table 98. Stryker Corporation Basic Information, Intracranial Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 99. Stryker Corporation Intracranial Embolization Coils Product Portfolios and Specifications
Table 100. Stryker Corporation Intracranial Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Stryker Corporation Main Business
Table 102. Stryker Corporation Latest Developments
Table 103. Medtronic plc Basic Information, Intracranial Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 104. Medtronic plc Intracranial Embolization Coils Product Portfolios and Specifications
Table 105. Medtronic plc Intracranial Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Medtronic plc Main Business
Table 107. Medtronic plc Latest Developments
Table 108. Johnson & Johnson Basic Information, Intracranial Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 109. Johnson & Johnson Intracranial Embolization Coils Product Portfolios and Specifications
Table 110. Johnson & Johnson Intracranial Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Johnson & Johnson Main Business
Table 112. Johnson & Johnson Latest Developments
Table 113. Terumo Corporation Basic Information, Intracranial Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 114. Terumo Corporation Intracranial Embolization Coils Product Portfolios and Specifications
Table 115. Terumo Corporation Intracranial Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Terumo Corporation Main Business
Table 117. Terumo Corporation Latest Developments
Table 118. Penumbra, Inc. Basic Information, Intracranial Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 119. Penumbra, Inc. Intracranial Embolization Coils Product Portfolios and Specifications
Table 120. Penumbra, Inc. Intracranial Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Penumbra, Inc. Main Business
Table 122. Penumbra, Inc. Latest Developments
Table 123. BALT SAS Basic Information, Intracranial Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 124. BALT SAS Intracranial Embolization Coils Product Portfolios and Specifications
Table 125. BALT SAS Intracranial Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. BALT SAS Main Business
Table 127. BALT SAS Latest Developments
Table 128. Kaneka Corporation Basic Information, Intracranial Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 129. Kaneka Corporation Intracranial Embolization Coils Product Portfolios and Specifications
Table 130. Kaneka Corporation Intracranial Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Kaneka Corporation Main Business
Table 132. Kaneka Corporation Latest Developments
Table 133. Genesis MedTech Group Basic Information, Intracranial Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 134. Genesis MedTech Group Intracranial Embolization Coils Product Portfolios and Specifications
Table 135. Genesis MedTech Group Intracranial Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Genesis MedTech Group Main Business
Table 137. Genesis MedTech Group Latest Developments
Table 138. Wallaby Medical Holding, Inc. Basic Information, Intracranial Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 139. Wallaby Medical Holding, Inc. Intracranial Embolization Coils Product Portfolios and Specifications
Table 140. Wallaby Medical Holding, Inc. Intracranial Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. Wallaby Medical Holding, Inc. Main Business
Table 142. Wallaby Medical Holding, Inc. Latest Developments
Table 143. MicroPort NeuroScientific Corporation Basic Information, Intracranial Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 144. MicroPort NeuroScientific Corporation Intracranial Embolization Coils Product Portfolios and Specifications
Table 145. MicroPort NeuroScientific Corporation Intracranial Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 146. MicroPort NeuroScientific Corporation Main Business
Table 147. MicroPort NeuroScientific Corporation Latest Developments
Table 148. Zylox-Tonbridge Medical Technology Co., Ltd. Basic Information, Intracranial Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 149. Zylox-Tonbridge Medical Technology Co., Ltd. Intracranial Embolization Coils Product Portfolios and Specifications
Table 150. Zylox-Tonbridge Medical Technology Co., Ltd. Intracranial Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 151. Zylox-Tonbridge Medical Technology Co., Ltd. Main Business
Table 152. Zylox-Tonbridge Medical Technology Co., Ltd. Latest Developments
Table 153. Shanghai HeartCare Medical Technology Corporation Limited Basic Information, Intracranial Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 154. Shanghai HeartCare Medical Technology Corporation Limited Intracranial Embolization Coils Product Portfolios and Specifications
Table 155. Shanghai HeartCare Medical Technology Corporation Limited Intracranial Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 156. Shanghai HeartCare Medical Technology Corporation Limited Main Business
Table 157. Shanghai HeartCare Medical Technology Corporation Limited Latest Developments
Table 158. Peijia Medical Limited Basic Information, Intracranial Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 159. Peijia Medical Limited Intracranial Embolization Coils Product Portfolios and Specifications
Table 160. Peijia Medical Limited Intracranial Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 161. Peijia Medical Limited Main Business
Table 162. Peijia Medical Limited Latest Developments
Table 163. Beijing Taijieweiye Technology Co., Ltd. Basic Information, Intracranial Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 164. Beijing Taijieweiye Technology Co., Ltd. Intracranial Embolization Coils Product Portfolios and Specifications
Table 165. Beijing Taijieweiye Technology Co., Ltd. Intracranial Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 166. Beijing Taijieweiye Technology Co., Ltd. Main Business
Table 167. Beijing Taijieweiye Technology Co., Ltd. Latest Developments
Table 168. Weigao Holding Co., Ltd. Basic Information, Intracranial Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 169. Weigao Holding Co., Ltd. Intracranial Embolization Coils Product Portfolios and Specifications
Table 170. Weigao Holding Co., Ltd. Intracranial Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 171. Weigao Holding Co., Ltd. Main Business
Table 172. Weigao Holding Co., Ltd. Latest Developments
Table 173. Shunmei Medical Co., Ltd. Basic Information, Intracranial Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 174. Shunmei Medical Co., Ltd. Intracranial Embolization Coils Product Portfolios and Specifications
Table 175. Shunmei Medical Co., Ltd. Intracranial Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 176. Shunmei Medical Co., Ltd. Main Business
Table 177. Shunmei Medical Co., Ltd. Latest Developments
Table 1. Intracranial Embolization Coils Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Intracranial Embolization Coils Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Bare Platinum Coils
Table 4. Major Players of Hydrogel-Enhanced Coils
Table 5. Major Players of Fiber-Enhanced Coils
Table 6. Major Players of Others
Table 7. Global Intracranial Embolization Coils Sales by Type (2021-2026) & (K Units)
Table 8. Global Intracranial Embolization Coils Sales Market Share by Type (2021-2026)
Table 9. Global Intracranial Embolization Coils Revenue by Type (2021-2026) & ($ million)
Table 10. Global Intracranial Embolization Coils Revenue Market Share by Type (2021-2026)
Table 11. Global Intracranial Embolization Coils Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Major Players of Three-Dimensional Complex Coils
Table 13. Major Players of Helical Coils
Table 14. Major Players of Others
Table 15. Global Intracranial Embolization Coils Sales by Coil Shape (2021-2026) & (K Units)
Table 16. Global Intracranial Embolization Coils Sales Market Share by Coil Shape (2021-2026)
Table 17. Global Intracranial Embolization Coils Revenue by Coil Shape (2021-2026) & ($ million)
Table 18. Global Intracranial Embolization Coils Revenue Market Share by Coil Shape (2021-2026)
Table 19. Global Intracranial Embolization Coils Sale Price by Coil Shape (2021-2026) & (US$/Unit)
Table 20. Major Players of Mechanical Detachment Coils
Table 21. Major Players of Electrolytic Detachment Coils
Table 22. Major Players of Others
Table 23. Global Intracranial Embolization Coils Sales by Detachment Method (2021-2026) & (K Units)
Table 24. Global Intracranial Embolization Coils Sales Market Share by Detachment Method (2021-2026)
Table 25. Global Intracranial Embolization Coils Revenue by Detachment Method (2021-2026) & ($ million)
Table 26. Global Intracranial Embolization Coils Revenue Market Share by Detachment Method (2021-2026)
Table 27. Global Intracranial Embolization Coils Sale Price by Detachment Method (2021-2026) & (US$/Unit)
Table 28. Major Players of Monofilament Reinforced Coils
Table 29. Major Players of Multifilament Reinforced Coils
Table 30. Major Players of Others
Table 31. Global Intracranial Embolization Coils Sales by Stretch Resistance Structure (2021-2026) & (K Units)
Table 32. Global Intracranial Embolization Coils Sales Market Share by Stretch Resistance Structure (2021-2026)
Table 33. Global Intracranial Embolization Coils Revenue by Stretch Resistance Structure (2021-2026) & ($ million)
Table 34. Global Intracranial Embolization Coils Revenue Market Share by Stretch Resistance Structure (2021-2026)
Table 35. Global Intracranial Embolization Coils Sale Price by Stretch Resistance Structure (2021-2026) & (US$/Unit)
Table 36. Global Intracranial Embolization Coils Sale by Application (2021-2026) & (K Units)
Table 37. Global Intracranial Embolization Coils Sale Market Share by Application (2021-2026)
Table 38. Global Intracranial Embolization Coils Revenue by Application (2021-2026) & ($ million)
Table 39. Global Intracranial Embolization Coils Revenue Market Share by Application (2021-2026)
Table 40. Global Intracranial Embolization Coils Sale Price by Application (2021-2026) & (US$/Unit)
Table 41. Global Intracranial Embolization Coils Sales by Company (2021-2026) & (K Units)
Table 42. Global Intracranial Embolization Coils Sales Market Share by Company (2021-2026)
Table 43. Global Intracranial Embolization Coils Revenue by Company (2021-2026) & ($ millions)
Table 44. Global Intracranial Embolization Coils Revenue Market Share by Company (2021-2026)
Table 45. Global Intracranial Embolization Coils Sale Price by Company (2021-2026) & (US$/Unit)
Table 46. Key Manufacturers Intracranial Embolization Coils Producing Area Distribution and Sales Area
Table 47. Players Intracranial Embolization Coils Products Offered
Table 48. Intracranial Embolization Coils Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 49. New Products and Potential Entrants
Table 50. Market M&A Activity & Strategy
Table 51. Global Intracranial Embolization Coils Sales by Geographic Region (2021-2026) & (K Units)
Table 52. Global Intracranial Embolization Coils Sales Market Share Geographic Region (2021-2026)
Table 53. Global Intracranial Embolization Coils Revenue by Geographic Region (2021-2026) & ($ millions)
Table 54. Global Intracranial Embolization Coils Revenue Market Share by Geographic Region (2021-2026)
Table 55. Global Intracranial Embolization Coils Sales by Country/Region (2021-2026) & (K Units)
Table 56. Global Intracranial Embolization Coils Sales Market Share by Country/Region (2021-2026)
Table 57. Global Intracranial Embolization Coils Revenue by Country/Region (2021-2026) & ($ millions)
Table 58. Global Intracranial Embolization Coils Revenue Market Share by Country/Region (2021-2026)
Table 59. Americas Intracranial Embolization Coils Sales by Country (2021-2026) & (K Units)
Table 60. Americas Intracranial Embolization Coils Sales Market Share by Country (2021-2026)
Table 61. Americas Intracranial Embolization Coils Revenue by Country (2021-2026) & ($ millions)
Table 62. Americas Intracranial Embolization Coils Sales by Type (2021-2026) & (K Units)
Table 63. Americas Intracranial Embolization Coils Sales by Application (2021-2026) & (K Units)
Table 64. APAC Intracranial Embolization Coils Sales by Region (2021-2026) & (K Units)
Table 65. APAC Intracranial Embolization Coils Sales Market Share by Region (2021-2026)
Table 66. APAC Intracranial Embolization Coils Revenue by Region (2021-2026) & ($ millions)
Table 67. APAC Intracranial Embolization Coils Sales by Type (2021-2026) & (K Units)
Table 68. APAC Intracranial Embolization Coils Sales by Application (2021-2026) & (K Units)
Table 69. Europe Intracranial Embolization Coils Sales by Country (2021-2026) & (K Units)
Table 70. Europe Intracranial Embolization Coils Revenue by Country (2021-2026) & ($ millions)
Table 71. Europe Intracranial Embolization Coils Sales by Type (2021-2026) & (K Units)
Table 72. Europe Intracranial Embolization Coils Sales by Application (2021-2026) & (K Units)
Table 73. Middle East & Africa Intracranial Embolization Coils Sales by Country (2021-2026) & (K Units)
Table 74. Middle East & Africa Intracranial Embolization Coils Revenue Market Share by Country (2021-2026)
Table 75. Middle East & Africa Intracranial Embolization Coils Sales by Type (2021-2026) & (K Units)
Table 76. Middle East & Africa Intracranial Embolization Coils Sales by Application (2021-2026) & (K Units)
Table 77. Key Market Drivers & Growth Opportunities of Intracranial Embolization Coils
Table 78. Key Market Challenges & Risks of Intracranial Embolization Coils
Table 79. Key Industry Trends of Intracranial Embolization Coils
Table 80. Intracranial Embolization Coils Raw Material
Table 81. Key Suppliers of Raw Materials
Table 82. Intracranial Embolization Coils Distributors List
Table 83. Intracranial Embolization Coils Customer List
Table 84. Global Intracranial Embolization Coils Sales Forecast by Region (2027-2032) & (K Units)
Table 85. Global Intracranial Embolization Coils Revenue Forecast by Region (2027-2032) & ($ millions)
Table 86. Americas Intracranial Embolization Coils Sales Forecast by Country (2027-2032) & (K Units)
Table 87. Americas Intracranial Embolization Coils Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 88. APAC Intracranial Embolization Coils Sales Forecast by Region (2027-2032) & (K Units)
Table 89. APAC Intracranial Embolization Coils Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 90. Europe Intracranial Embolization Coils Sales Forecast by Country (2027-2032) & (K Units)
Table 91. Europe Intracranial Embolization Coils Revenue Forecast by Country (2027-2032) & ($ millions)
Table 92. Middle East & Africa Intracranial Embolization Coils Sales Forecast by Country (2027-2032) & (K Units)
Table 93. Middle East & Africa Intracranial Embolization Coils Revenue Forecast by Country (2027-2032) & ($ millions)
Table 94. Global Intracranial Embolization Coils Sales Forecast by Type (2027-2032) & (K Units)
Table 95. Global Intracranial Embolization Coils Revenue Forecast by Type (2027-2032) & ($ millions)
Table 96. Global Intracranial Embolization Coils Sales Forecast by Application (2027-2032) & (K Units)
Table 97. Global Intracranial Embolization Coils Revenue Forecast by Application (2027-2032) & ($ millions)
Table 98. Stryker Corporation Basic Information, Intracranial Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 99. Stryker Corporation Intracranial Embolization Coils Product Portfolios and Specifications
Table 100. Stryker Corporation Intracranial Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Stryker Corporation Main Business
Table 102. Stryker Corporation Latest Developments
Table 103. Medtronic plc Basic Information, Intracranial Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 104. Medtronic plc Intracranial Embolization Coils Product Portfolios and Specifications
Table 105. Medtronic plc Intracranial Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Medtronic plc Main Business
Table 107. Medtronic plc Latest Developments
Table 108. Johnson & Johnson Basic Information, Intracranial Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 109. Johnson & Johnson Intracranial Embolization Coils Product Portfolios and Specifications
Table 110. Johnson & Johnson Intracranial Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Johnson & Johnson Main Business
Table 112. Johnson & Johnson Latest Developments
Table 113. Terumo Corporation Basic Information, Intracranial Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 114. Terumo Corporation Intracranial Embolization Coils Product Portfolios and Specifications
Table 115. Terumo Corporation Intracranial Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Terumo Corporation Main Business
Table 117. Terumo Corporation Latest Developments
Table 118. Penumbra, Inc. Basic Information, Intracranial Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 119. Penumbra, Inc. Intracranial Embolization Coils Product Portfolios and Specifications
Table 120. Penumbra, Inc. Intracranial Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Penumbra, Inc. Main Business
Table 122. Penumbra, Inc. Latest Developments
Table 123. BALT SAS Basic Information, Intracranial Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 124. BALT SAS Intracranial Embolization Coils Product Portfolios and Specifications
Table 125. BALT SAS Intracranial Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. BALT SAS Main Business
Table 127. BALT SAS Latest Developments
Table 128. Kaneka Corporation Basic Information, Intracranial Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 129. Kaneka Corporation Intracranial Embolization Coils Product Portfolios and Specifications
Table 130. Kaneka Corporation Intracranial Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Kaneka Corporation Main Business
Table 132. Kaneka Corporation Latest Developments
Table 133. Genesis MedTech Group Basic Information, Intracranial Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 134. Genesis MedTech Group Intracranial Embolization Coils Product Portfolios and Specifications
Table 135. Genesis MedTech Group Intracranial Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Genesis MedTech Group Main Business
Table 137. Genesis MedTech Group Latest Developments
Table 138. Wallaby Medical Holding, Inc. Basic Information, Intracranial Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 139. Wallaby Medical Holding, Inc. Intracranial Embolization Coils Product Portfolios and Specifications
Table 140. Wallaby Medical Holding, Inc. Intracranial Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. Wallaby Medical Holding, Inc. Main Business
Table 142. Wallaby Medical Holding, Inc. Latest Developments
Table 143. MicroPort NeuroScientific Corporation Basic Information, Intracranial Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 144. MicroPort NeuroScientific Corporation Intracranial Embolization Coils Product Portfolios and Specifications
Table 145. MicroPort NeuroScientific Corporation Intracranial Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 146. MicroPort NeuroScientific Corporation Main Business
Table 147. MicroPort NeuroScientific Corporation Latest Developments
Table 148. Zylox-Tonbridge Medical Technology Co., Ltd. Basic Information, Intracranial Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 149. Zylox-Tonbridge Medical Technology Co., Ltd. Intracranial Embolization Coils Product Portfolios and Specifications
Table 150. Zylox-Tonbridge Medical Technology Co., Ltd. Intracranial Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 151. Zylox-Tonbridge Medical Technology Co., Ltd. Main Business
Table 152. Zylox-Tonbridge Medical Technology Co., Ltd. Latest Developments
Table 153. Shanghai HeartCare Medical Technology Corporation Limited Basic Information, Intracranial Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 154. Shanghai HeartCare Medical Technology Corporation Limited Intracranial Embolization Coils Product Portfolios and Specifications
Table 155. Shanghai HeartCare Medical Technology Corporation Limited Intracranial Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 156. Shanghai HeartCare Medical Technology Corporation Limited Main Business
Table 157. Shanghai HeartCare Medical Technology Corporation Limited Latest Developments
Table 158. Peijia Medical Limited Basic Information, Intracranial Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 159. Peijia Medical Limited Intracranial Embolization Coils Product Portfolios and Specifications
Table 160. Peijia Medical Limited Intracranial Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 161. Peijia Medical Limited Main Business
Table 162. Peijia Medical Limited Latest Developments
Table 163. Beijing Taijieweiye Technology Co., Ltd. Basic Information, Intracranial Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 164. Beijing Taijieweiye Technology Co., Ltd. Intracranial Embolization Coils Product Portfolios and Specifications
Table 165. Beijing Taijieweiye Technology Co., Ltd. Intracranial Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 166. Beijing Taijieweiye Technology Co., Ltd. Main Business
Table 167. Beijing Taijieweiye Technology Co., Ltd. Latest Developments
Table 168. Weigao Holding Co., Ltd. Basic Information, Intracranial Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 169. Weigao Holding Co., Ltd. Intracranial Embolization Coils Product Portfolios and Specifications
Table 170. Weigao Holding Co., Ltd. Intracranial Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 171. Weigao Holding Co., Ltd. Main Business
Table 172. Weigao Holding Co., Ltd. Latest Developments
Table 173. Shunmei Medical Co., Ltd. Basic Information, Intracranial Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 174. Shunmei Medical Co., Ltd. Intracranial Embolization Coils Product Portfolios and Specifications
Table 175. Shunmei Medical Co., Ltd. Intracranial Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 176. Shunmei Medical Co., Ltd. Main Business
Table 177. Shunmei Medical Co., Ltd. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Intracranial Embolization Coils
Figure 2. Intracranial Embolization Coils Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Intracranial Embolization Coils Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Intracranial Embolization Coils Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Intracranial Embolization Coils Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Intracranial Embolization Coils Sales Market Share by Country/Region (2025)
Figure 10. Intracranial Embolization Coils Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Bare Platinum Coils
Figure 12. Product Picture of Hydrogel-Enhanced Coils
Figure 13. Product Picture of Fiber-Enhanced Coils
Figure 14. Product Picture of Others
Figure 15. Global Intracranial Embolization Coils Sales Market Share by Type in 2026
Figure 16. Global Intracranial Embolization Coils Revenue Market Share by Type (2021-2026)
Figure 17. Product Picture of Three-Dimensional Complex Coils
Figure 18. Product Picture of Helical Coils
Figure 19. Product Picture of Others
Figure 20. Global Intracranial Embolization Coils Sales Market Share by Coil Shape in 2026
Figure 21. Global Intracranial Embolization Coils Revenue Market Share by Coil Shape (2021-2026)
Figure 22. Product Picture of Mechanical Detachment Coils
Figure 23. Product Picture of Electrolytic Detachment Coils
Figure 24. Product Picture of Others
Figure 25. Global Intracranial Embolization Coils Sales Market Share by Detachment Method in 2026
Figure 26. Global Intracranial Embolization Coils Revenue Market Share by Detachment Method (2021-2026)
Figure 27. Product Picture of Monofilament Reinforced Coils
Figure 28. Product Picture of Multifilament Reinforced Coils
Figure 29. Product Picture of Others
Figure 30. Global Intracranial Embolization Coils Sales Market Share by Stretch Resistance Structure in 2026
Figure 31. Global Intracranial Embolization Coils Revenue Market Share by Stretch Resistance Structure (2021-2026)
Figure 32. Intracranial Embolization Coils Consumed in Intracranial Aneurysm
Figure 33. Global Intracranial Embolization Coils Market: Intracranial Aneurysm (2021-2026) & (K Units)
Figure 34. Intracranial Embolization Coils Consumed in Arteriovenous Malformation (AVM)
Figure 35. Global Intracranial Embolization Coils Market: Arteriovenous Malformation (AVM) (2021-2026) & (K Units)
Figure 36. Intracranial Embolization Coils Consumed in Cerebral Infarction
Figure 37. Global Intracranial Embolization Coils Market: Cerebral Infarction (2021-2026) & (K Units)
Figure 38. Intracranial Embolization Coils Consumed in Others
Figure 39. Global Intracranial Embolization Coils Market: Others (2021-2026) & (K Units)
Figure 40. Global Intracranial Embolization Coils Sale Market Share by Application (2025)
Figure 41. Global Intracranial Embolization Coils Revenue Market Share by Application in 2025
Figure 42. Intracranial Embolization Coils Sales by Company in 2025 (K Units)
Figure 43. Global Intracranial Embolization Coils Sales Market Share by Company in 2025
Figure 44. Intracranial Embolization Coils Revenue by Company in 2025 ($ millions)
Figure 45. Global Intracranial Embolization Coils Revenue Market Share by Company in 2025
Figure 46. Global Intracranial Embolization Coils Sales Market Share by Geographic Region (2021-2026)
Figure 47. Global Intracranial Embolization Coils Revenue Market Share by Geographic Region in 2025
Figure 48. Americas Intracranial Embolization Coils Sales 2021-2026 (K Units)
Figure 49. Americas Intracranial Embolization Coils Revenue 2021-2026 ($ millions)
Figure 50. APAC Intracranial Embolization Coils Sales 2021-2026 (K Units)
Figure 51. APAC Intracranial Embolization Coils Revenue 2021-2026 ($ millions)
Figure 52. Europe Intracranial Embolization Coils Sales 2021-2026 (K Units)
Figure 53. Europe Intracranial Embolization Coils Revenue 2021-2026 ($ millions)
Figure 54. Middle East & Africa Intracranial Embolization Coils Sales 2021-2026 (K Units)
Figure 55. Middle East & Africa Intracranial Embolization Coils Revenue 2021-2026 ($ millions)
Figure 56. Americas Intracranial Embolization Coils Sales Market Share by Country in 2025
Figure 57. Americas Intracranial Embolization Coils Revenue Market Share by Country (2021-2026)
Figure 58. Americas Intracranial Embolization Coils Sales Market Share by Type (2021-2026)
Figure 59. Americas Intracranial Embolization Coils Sales Market Share by Application (2021-2026)
Figure 60. United States Intracranial Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 61. Canada Intracranial Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 62. Mexico Intracranial Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 63. Brazil Intracranial Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 64. APAC Intracranial Embolization Coils Sales Market Share by Region in 2025
Figure 65. APAC Intracranial Embolization Coils Revenue Market Share by Region (2021-2026)
Figure 66. APAC Intracranial Embolization Coils Sales Market Share by Type (2021-2026)
Figure 67. APAC Intracranial Embolization Coils Sales Market Share by Application (2021-2026)
Figure 68. China Intracranial Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 69. Japan Intracranial Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 70. South Korea Intracranial Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 71. Southeast Asia Intracranial Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 72. India Intracranial Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 73. Australia Intracranial Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 74. China Taiwan Intracranial Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 75. Europe Intracranial Embolization Coils Sales Market Share by Country in 2025
Figure 76. Europe Intracranial Embolization Coils Revenue Market Share by Country (2021-2026)
Figure 77. Europe Intracranial Embolization Coils Sales Market Share by Type (2021-2026)
Figure 78. Europe Intracranial Embolization Coils Sales Market Share by Application (2021-2026)
Figure 79. Germany Intracranial Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 80. France Intracranial Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 81. UK Intracranial Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 82. Italy Intracranial Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 83. Russia Intracranial Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 84. Middle East & Africa Intracranial Embolization Coils Sales Market Share by Country (2021-2026)
Figure 85. Middle East & Africa Intracranial Embolization Coils Sales Market Share by Type (2021-2026)
Figure 86. Middle East & Africa Intracranial Embolization Coils Sales Market Share by Application (2021-2026)
Figure 87. Egypt Intracranial Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 88. South Africa Intracranial Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 89. Israel Intracranial Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 90. Turkey Intracranial Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 91. GCC Countries Intracranial Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 92. Manufacturing Cost Structure Analysis of Intracranial Embolization Coils in 2026
Figure 93. Manufacturing Process Analysis of Intracranial Embolization Coils
Figure 94. Industry Chain Structure of Intracranial Embolization Coils
Figure 95. Channels of Distribution
Figure 96. Global Intracranial Embolization Coils Sales Market Forecast by Region (2027-2032)
Figure 97. Global Intracranial Embolization Coils Revenue Market Share Forecast by Region (2027-2032)
Figure 98. Global Intracranial Embolization Coils Sales Market Share Forecast by Type (2027-2032)
Figure 99. Global Intracranial Embolization Coils Revenue Market Share Forecast by Type (2027-2032)
Figure 100. Global Intracranial Embolization Coils Sales Market Share Forecast by Application (2027-2032)
Figure 101. Global Intracranial Embolization Coils Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Intracranial Embolization Coils
Figure 2. Intracranial Embolization Coils Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Intracranial Embolization Coils Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Intracranial Embolization Coils Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Intracranial Embolization Coils Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Intracranial Embolization Coils Sales Market Share by Country/Region (2025)
Figure 10. Intracranial Embolization Coils Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Bare Platinum Coils
Figure 12. Product Picture of Hydrogel-Enhanced Coils
Figure 13. Product Picture of Fiber-Enhanced Coils
Figure 14. Product Picture of Others
Figure 15. Global Intracranial Embolization Coils Sales Market Share by Type in 2026
Figure 16. Global Intracranial Embolization Coils Revenue Market Share by Type (2021-2026)
Figure 17. Product Picture of Three-Dimensional Complex Coils
Figure 18. Product Picture of Helical Coils
Figure 19. Product Picture of Others
Figure 20. Global Intracranial Embolization Coils Sales Market Share by Coil Shape in 2026
Figure 21. Global Intracranial Embolization Coils Revenue Market Share by Coil Shape (2021-2026)
Figure 22. Product Picture of Mechanical Detachment Coils
Figure 23. Product Picture of Electrolytic Detachment Coils
Figure 24. Product Picture of Others
Figure 25. Global Intracranial Embolization Coils Sales Market Share by Detachment Method in 2026
Figure 26. Global Intracranial Embolization Coils Revenue Market Share by Detachment Method (2021-2026)
Figure 27. Product Picture of Monofilament Reinforced Coils
Figure 28. Product Picture of Multifilament Reinforced Coils
Figure 29. Product Picture of Others
Figure 30. Global Intracranial Embolization Coils Sales Market Share by Stretch Resistance Structure in 2026
Figure 31. Global Intracranial Embolization Coils Revenue Market Share by Stretch Resistance Structure (2021-2026)
Figure 32. Intracranial Embolization Coils Consumed in Intracranial Aneurysm
Figure 33. Global Intracranial Embolization Coils Market: Intracranial Aneurysm (2021-2026) & (K Units)
Figure 34. Intracranial Embolization Coils Consumed in Arteriovenous Malformation (AVM)
Figure 35. Global Intracranial Embolization Coils Market: Arteriovenous Malformation (AVM) (2021-2026) & (K Units)
Figure 36. Intracranial Embolization Coils Consumed in Cerebral Infarction
Figure 37. Global Intracranial Embolization Coils Market: Cerebral Infarction (2021-2026) & (K Units)
Figure 38. Intracranial Embolization Coils Consumed in Others
Figure 39. Global Intracranial Embolization Coils Market: Others (2021-2026) & (K Units)
Figure 40. Global Intracranial Embolization Coils Sale Market Share by Application (2025)
Figure 41. Global Intracranial Embolization Coils Revenue Market Share by Application in 2025
Figure 42. Intracranial Embolization Coils Sales by Company in 2025 (K Units)
Figure 43. Global Intracranial Embolization Coils Sales Market Share by Company in 2025
Figure 44. Intracranial Embolization Coils Revenue by Company in 2025 ($ millions)
Figure 45. Global Intracranial Embolization Coils Revenue Market Share by Company in 2025
Figure 46. Global Intracranial Embolization Coils Sales Market Share by Geographic Region (2021-2026)
Figure 47. Global Intracranial Embolization Coils Revenue Market Share by Geographic Region in 2025
Figure 48. Americas Intracranial Embolization Coils Sales 2021-2026 (K Units)
Figure 49. Americas Intracranial Embolization Coils Revenue 2021-2026 ($ millions)
Figure 50. APAC Intracranial Embolization Coils Sales 2021-2026 (K Units)
Figure 51. APAC Intracranial Embolization Coils Revenue 2021-2026 ($ millions)
Figure 52. Europe Intracranial Embolization Coils Sales 2021-2026 (K Units)
Figure 53. Europe Intracranial Embolization Coils Revenue 2021-2026 ($ millions)
Figure 54. Middle East & Africa Intracranial Embolization Coils Sales 2021-2026 (K Units)
Figure 55. Middle East & Africa Intracranial Embolization Coils Revenue 2021-2026 ($ millions)
Figure 56. Americas Intracranial Embolization Coils Sales Market Share by Country in 2025
Figure 57. Americas Intracranial Embolization Coils Revenue Market Share by Country (2021-2026)
Figure 58. Americas Intracranial Embolization Coils Sales Market Share by Type (2021-2026)
Figure 59. Americas Intracranial Embolization Coils Sales Market Share by Application (2021-2026)
Figure 60. United States Intracranial Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 61. Canada Intracranial Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 62. Mexico Intracranial Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 63. Brazil Intracranial Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 64. APAC Intracranial Embolization Coils Sales Market Share by Region in 2025
Figure 65. APAC Intracranial Embolization Coils Revenue Market Share by Region (2021-2026)
Figure 66. APAC Intracranial Embolization Coils Sales Market Share by Type (2021-2026)
Figure 67. APAC Intracranial Embolization Coils Sales Market Share by Application (2021-2026)
Figure 68. China Intracranial Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 69. Japan Intracranial Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 70. South Korea Intracranial Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 71. Southeast Asia Intracranial Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 72. India Intracranial Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 73. Australia Intracranial Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 74. China Taiwan Intracranial Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 75. Europe Intracranial Embolization Coils Sales Market Share by Country in 2025
Figure 76. Europe Intracranial Embolization Coils Revenue Market Share by Country (2021-2026)
Figure 77. Europe Intracranial Embolization Coils Sales Market Share by Type (2021-2026)
Figure 78. Europe Intracranial Embolization Coils Sales Market Share by Application (2021-2026)
Figure 79. Germany Intracranial Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 80. France Intracranial Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 81. UK Intracranial Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 82. Italy Intracranial Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 83. Russia Intracranial Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 84. Middle East & Africa Intracranial Embolization Coils Sales Market Share by Country (2021-2026)
Figure 85. Middle East & Africa Intracranial Embolization Coils Sales Market Share by Type (2021-2026)
Figure 86. Middle East & Africa Intracranial Embolization Coils Sales Market Share by Application (2021-2026)
Figure 87. Egypt Intracranial Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 88. South Africa Intracranial Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 89. Israel Intracranial Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 90. Turkey Intracranial Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 91. GCC Countries Intracranial Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 92. Manufacturing Cost Structure Analysis of Intracranial Embolization Coils in 2026
Figure 93. Manufacturing Process Analysis of Intracranial Embolization Coils
Figure 94. Industry Chain Structure of Intracranial Embolization Coils
Figure 95. Channels of Distribution
Figure 96. Global Intracranial Embolization Coils Sales Market Forecast by Region (2027-2032)
Figure 97. Global Intracranial Embolization Coils Revenue Market Share Forecast by Region (2027-2032)
Figure 98. Global Intracranial Embolization Coils Sales Market Share Forecast by Type (2027-2032)
Figure 99. Global Intracranial Embolization Coils Revenue Market Share Forecast by Type (2027-2032)
Figure 100. Global Intracranial Embolization Coils Sales Market Share Forecast by Application (2027-2032)
Figure 101. Global Intracranial Embolization Coils Revenue Market Share Forecast by Application (2027-2032)
